ResearcherUniversity of California, Los AngelesNo recent work listed

Tien Sy Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0105-8063; OpenAlex author ID A5029167819. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity. Co-author DOI 10.1152/ajpgi.00170.2019 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui-Hua Chang · 1 shared paper, 2019 · strength 0.10
- Paper Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by di… DOI 10.1152/ajpgi.00170.2019 ↗
Guido Eibl · 1 shared paper, 2019 · strength 0.10
- Paper Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by di… DOI 10.1152/ajpgi.00170.2019 ↗
Enrique Rozengurt · 1 shared paper, 2019 · strength 0.10
- Paper Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by di… DOI 10.1152/ajpgi.00170.2019 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.